Abstract Body

Background: HIV is a recognized risk factor for osteoporosis. The role of soluble markers and cellular immune parameters on HIV-related bone loss remains unclear.

Methods: We evaluated inflammatory markers and total hip bone mineral density (BMD) changes in a prospective HIV cohort enrolled during 2004-2006 (SUN Study). We abstracted clinical data & measured BMD by dual-energy X-ray absorptiometry (DXA) at baseline & annually for 4 years. We characterized soluble inflammatory biomarkers & cellular immunophenotypes by multi-color ow cytometry of baseline cryopreserved peripheral blood mononuclear cells, assessed the correlation between baseline BMD & immune parameters, and identified predictors of percent change in BMD from baseline by longitudinal regression after adjusting for traditional & HIV-related risk factors.

Results: Baseline characteristics (n=637): median age 41 yrs, 77% male, median CD4 ct 471c/mm3, and 74% plasma HIV RNA level <400 cp/mL. There were 554 subjects with 1887 yrs of follow up (median 4 yrs) and a median of 4 DXAs per participant. At baseline and final DXA, 387 (61%) and 393 (62%) had low BMD (T score <-1.0), respectively. sCD14, but not IL-6, was inversely correlated with total hip BMD at baseline (p<0.01 & 0.08, respectively). No T-cell phenotypes correlated with baseline hip BMD while several monocyte phenotypes correlated either positively (CX3CR1+; CD14dimCD16+; CD14varCD16+) or negatively (CCR2+; CD14+CD16-) with baseline hip BMD (p<0.01 for all). Associations between baseline soluble biomarkers and frequencies of immunophenotypes with changes in total hip BMD were adjusted for traditional (model 1) and HIV-related risk factors (model 2) (see table). Having a higher prevalence of memory CD28+ CD4+ and CD8+ T-cells was associated with increasing total hip BMD (p<0.001 for both). IL-6, replicatively senescent CD4 T-cells, and monocytes expressing CCR5+ or tissue factor were associated with total hip BMD decline (p=0.01, 0.03, & 0.05, respectively). For T-cell activation phenotypes and other monocyte phenotypes, no apparent association with change in total hip BMD was identified.

Conclusions: In this healthy HIV adult cohort with predominantly controlled viremia, total hip BMD decline was associated with IL-6, replicative senescent T-cells, CCR5+ and tissue factor expressing monocytes. Memory CD4+ and CD8+ CD28+ T cells were associated with increases in BMD. Immunologic alterations that persist after virologic suppression may contribute to ongoing loss of BMD.

viewer?TAG_ACTION=SECURE_FILE_DOWNLOAD&V